Verapamil hydrochloride
- Product NDC
- 68083-447
- 11-digit product format
- 680830447
- Labeler code
- 68083
- Product ID
- 68083-447_97d5fbfc-783f-4d2d-a178-1ac1ff0d6a55
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Verapamil hydrochloride
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Labeler
- Gland Pharma Limited
- Application
- ANDA214361
- Marketing category
- ANDA
- Marketing start
- 2020-10-15
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 2.5 mg/mL
- Pharmacologic classes
- Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V3888OEY5R | VERAPAMIL HYDROCHLORIDE | 152-11-4 | VERAPAMIL HYDROCHLORIDE |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 68083-447-25 | 68083044725 | 25 VIAL in 1 CARTON (68083-447-25) / 2 mL in 1 VIAL | 25 vial | 2020-10-15 | No | No | Historical |